Cargando…
Alzheimer's disease: Unique markers for diagnosis & new treatment modalities
Alzheimer's disease (AD) is a progressive and irreversible neurodegenerative disease. In humans, AD becomes symptomatic only after brain changes occur over years or decades. Three contiguous phases of AD have been proposed: (i) the AD pathophysiologic process, (ii) mild cognitive impairment due...
Autores principales: | Aggarwal, Neelum T., Shah, Raj C., Bennett, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683821/ https://www.ncbi.nlm.nih.gov/pubmed/26609028 http://dx.doi.org/10.4103/0971-5916.169193 |
Ejemplares similares
-
New treatment modalities in Alzheimer's disease
por: Koseoglu, Emel
Publicado: (2019) -
Neuroimaging Modalities in Alzheimer’s Disease: Diagnosis and Clinical Features
por: Kim, JunHyun, et al.
Publicado: (2022) -
Infusing Representativeness and Cultivating Harmonization in Alzheimer’s Trials: World Wide FINGERS
por: Raman, Rema, et al.
Publicado: (2021) -
Potential Peripheral Biomarkers for the Diagnosis of Alzheimer's Disease
por: Patel, Seema, et al.
Publicado: (2011) -
Trends in Alzheimer's Disease and Dementia in the Asian-Pacific Region
por: Aggarwal, Neelum T., et al.
Publicado: (2012)